Not Tagged
Not Tagged
['myeloid', 'leukemia']
dr. david sallman of discusses the need for treatments in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. check out his presentation on abstract 4633 at #ash22, today, monday, dec. 12, from 6-8pm ct. 
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies.